NCT05828082 2026-04-14
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT01841723 2026-04-13
Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00352534 2026-02-18
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Children's Oncology Group
Phase 3 Active not recruiting
NCT02176967 2025-12-22
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Children's Oncology Group
Phase 3 Active not recruiting
NCT03672331 2025-09-18
MyPeBS
UNICANCER
Phase NA Active not recruiting
NCT05336786 2025-09-04
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
Thomas Jefferson University
Phase 3 Active not recruiting
NCT02276443 2025-08-01
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT01696994 2025-07-23
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
NCT03278925 2024-08-02
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis
National Cancer Institute (NCI)
Phase 1 Active not recruiting